| 1998 |
RbAp46 (RBBP7) is a transcriptional target of Wilms' tumor suppressor WT1; WT1 upregulates RbAp46 ~15-fold, and RbAp46 overexpression inhibits cell growth and colony formation, establishing it as a growth inhibitor downstream of WT1. |
Suppression subtractive hybridization PCR to identify WT1 target genes; transfection of RbAp46 cDNA with colony formation and growth rate assays |
The Journal of biological chemistry |
Medium |
9765217
|
| 2001 |
RbAp46 (RBBP7) interacts specifically with the BRCT domain of BRCA1 via its first two WD-repeats; this interaction represses BRCA1-mediated transactivation of the p21 promoter, and is disrupted by DNA-damaging agents. |
Yeast two-hybrid screening; co-immunoprecipitation; luciferase reporter assay for p21 promoter transactivation; domain mapping by deletion mutagenesis |
Biochemical and biophysical research communications |
Medium |
11394910
|
| 2001 |
RbAp46 (RBBP7) overexpression in adenovirus-transformed HEK293 cells suppresses clonal growth in soft agar and tumor growth in nude mice, increases G2/M fraction, and augments apoptosis under serum starvation, indicating a role in cell cycle control and apoptosis. |
Stable transfection; soft agar colony formation; nude mouse xenograft; flow cytometry cell cycle analysis; serum starvation apoptosis assay |
International journal of cancer |
Medium |
11433396
|
| 2003 |
Inducible RbAp46 expression activates the JNK (c-Jun NH2-terminal kinase) signaling pathway and triggers apoptosis; a dominant-negative JNK1 mutant blocks RbAp46-mediated apoptosis, placing RbAp46 upstream of JNK in this pathway. |
Tetracycline-inducible expression system; JNK activity assay; dominant-negative JNK1 epistasis; tumor xenograft in nude mice |
Anticancer research |
Medium |
14981905
|
| 2003 |
Overexpression of RbAp46 in neoplastigenic MCF10AT3B breast epithelial cells constitutively activates the JNK pathway and GADD45, sensitizing cells to apoptosis induced by serum deprivation and hydrocortisone withdrawal. |
Stable cell line establishment; soft agar colony formation; nude mouse xenograft; Western blot for JNK and GADD45 activation |
International journal of cancer |
Medium |
12767060
|
| 2004 |
Drosophila p55 (ortholog of RbAp46/RbAp48/RBBP7) is essential for repression of dE2F2-regulated target genes by the pRB-related proteins RBF1 and RBF2; its depletion deregulates E2F targets in a cell cycle-independent manner without affecting proliferation-coupled E2F targets, indicating mechanistically distinct repression modes. |
RNAi depletion of p55 in Drosophila cells; RT-PCR and reporter assays for E2F target gene expression; genetic epistasis with dE2F2/RBF complexes |
Molecular and cellular biology |
High |
15456884
|
| 2006 |
RbAp46 expression in mammary epithelial cells upregulates GSK-3β expression, leading to increased phosphorylation and reduced steady-state levels of β-catenin and decreased β-catenin/TCF nuclear signaling. |
Stable cell line expressing RbAp46; Western blot for β-catenin phosphorylation and GSK-3β; TCF luciferase reporter assay; cell growth assay |
Anticancer research |
Low |
17201172
|
| 2006 |
Constitutive RbAp46 expression in MCF10AT3B mammary epithelial cells induces epithelial-mesenchymal transition (EMT), characterized by downregulation of epithelial markers, upregulation of mesenchymal markers, and increased migration and invasion. |
Western blot and immunofluorescence for EMT markers; migration and invasion assays (Transwell) |
Anticancer research |
Low |
17094482
|
| 2008 |
SUMO-1 physically interacts with RbAp46 and co-localizes in the nucleus; SUMO-1 overexpression increases RbAp46 protein stability (not at the transcriptional level and not via sumoylation of RbAp46), and this stabilization enhances RbAp46-mediated suppression of Ras-driven cell growth. |
Co-immunoprecipitation; co-localization by immunofluorescence; Western blot for protein levels with transcription and degradation controls; cell growth assay |
Anticancer research |
Medium |
19189660
|
| 2015 |
RbAp46 (RBBP7) binds with HDAC1 and Sp1, and this complex binds to the RECK promoter at the Sp1 site, repressing RECK expression; Ras upregulates RbAp46 to suppress RECK and increase MMP-9 activity, promoting metastasis. |
Chromatin immunoprecipitation (ChIP); DNA affinity precipitation assay (DAPA); RECK reporter gene assay; lentiviral shRNA knockdown; xenograft lung metastasis model |
BMC cancer |
Medium |
25885317
|
| 2015 |
RBBP7 is a substrate-specific adaptor (DCAF) for the CRL4 E3 ubiquitin ligase complex (CUL4/DDB1/ROC1); as CRL4(RBBP7), it is required for centromeric loading of newly synthesized CENP-A during G1 phase, in addition to binding and stabilizing soluble CENP-A. |
Biochemical fractionation; quantitative imaging; RNAi depletion of CUL4, DDB1, and RBBP7; CENP-A localization assays by fluorescence microscopy |
Journal of cell science |
Medium |
25795299
|
| 2015 |
Rbbp7 knockdown in mouse oocytes prevents maturation-associated histone deacetylation, which in turn disrupts chromosomal passenger complex (CPC) localization and function, leading to chromosome misalignment, improper kinetochore-microtubule attachments, impaired spindle assembly checkpoint, cytokinesis defects, and aneuploidy at metaphase II. |
siRNA/morpholino knockdown; Western blot for histone acetylation; immunofluorescence for CPC components; kinetochore-microtubule attachment assays; spindle assembly checkpoint assay; aneuploidy scoring |
Cell cycle (Georgetown, Tex.) |
High |
24317350
|
| 2015 |
Rbbp7 silencing in mouse uterine stromal cells attenuates histone H4 acetylation and reduces cyclin D3 expression, compromising stromal cell decidualization; Rbbp7 expression is induced by progesterone/nuclear receptor PR signaling. |
In situ hybridization; immunochemistry; stealth RNA knockdown; primary murine uterine stromal cell culture; in vitro decidualization model; Western blot |
Biology of reproduction |
Medium |
26040671
|
| 2016 |
C. elegans RbAp46/48 (LIN-53, ortholog of RBBP7) is required for CENP-A(HCP-3) localization at holocentromeres; LIN-53 and CENP-A localizations are interdependent, and LIN-53 localization at the centromere during metaphase requires both CENP-A(HCP-3) and M18BP1(KNL-2). This function is independent of histone acetylation, H3K27 trimethylation, or known chromatin-modifying complexes. |
RNAi depletion; immunofluorescence for CENP-A and kinetochore components; epistasis analysis with KNL-2; anaphase bridge and chromosome missegregation scoring |
Cell reports |
High |
26904949
|
| 2017 |
AMPK directly phosphorylates RBBP7 at an AMPK consensus sequence; this phosphorylation increases interaction between RBBP7 and DNMT1, contributing to inhibition of DNMT1-mediated DNA methylation and promoting nucleosome remodeling for mitochondrial gene expression. |
Identification of AMPK phosphorylation consensus in RBBP7; co-immunoprecipitation showing increased RBBP7-DNMT1 interaction upon AMPK activation; pharmacological AMPK activation in HUVECs and mouse aorta; methylation assays |
Science signaling |
Medium |
28143904
|
| 2017 |
The human MTA2-RBBP7 sub-complex of the NuRD complex can be isolated as a stable complex in vitro; negative stain electron microscopy reveals an elongated architecture with hinge-like motion, consistent with the 2:4 stoichiometry (MTA:RBBP) seen in Drosophila NuRD. |
Recombinant expression in HEK293F cells; affinity purification; negative stain electron microscopy and 3D reconstruction |
Biochimica et biophysica acta. Proteins and proteomics |
Medium |
28179136
|
| 2018 |
RBBP7 functions as the DCAF substrate receptor in the CRL4B (DDB1-CUL4B-ROC1) E3 ubiquitin ligase complex, bridging the complex to HUWE1 and mediating its polyubiquitination and proteasomal degradation; RBBP7 depletion stabilizes HUWE1 and accelerates degradation of MCL-1 and BRCA1 (HUWE1 substrates). |
Co-immunoprecipitation; ubiquitination assay in vitro and in cells; RBBP7 overexpression and depletion with Western blot for HUWE1, MCL-1, and BRCA1 levels |
Biochemical and biophysical research communications |
Medium |
29738775
|
| 2021 |
Double knockdown of Rbbp4 and Rbbp7 (but not individual knockdowns) causes embryonic lethality at the morula-to-blastocyst transition in mice, with cell cycle block, disrupted lineage specification, and a dramatic increase in H3.3 and H3K27ac abundance; ChIP-seq reveals H3.3 enrichment at promoters of RBBP4/7 target genes, indicating compensatory roles in H3.3 deposition and chromatin regulation. |
siRNA double knockdown in preimplantation embryos; ChIP-seq for H3.3 and H3K27ac; RNA-seq for gene expression; immunofluorescence for lineage markers |
Epigenetics |
High |
34709113
|
| 2021 |
Rbbp7 overexpression in hippocampal neurons reduces p300 levels, decreases tau acetylation at lysine 280, and reduces tau phosphorylation at AT8 and AT100 sites, thereby protecting against tau-induced neuronal death; in vitro Rbbp7 overexpression rescues TauP301L-induced cytotoxicity. |
Rbbp7 viral overexpression in PS19 mouse hippocampus; Western blot for p300, tau acetylation, and phosphorylation; neuronal survival quantification in CA1; cell viability assays in immortalized hippocampal cells and primary cortical neurons |
Acta neuropathologica |
Medium |
33978814
|
| 2021 |
C. elegans RbAp46/48 (LIN-53) and HAT-1 are required for de novo CENP-A(HCP-3) and Mis18BP1(KNL-2) initial deposition at newly formed centromeres on artificial chromosomes; this requirement differs from centromere maintenance on endogenous chromosomes where KNL-2 acts upstream of LIN-53. |
RNAi depletion; microinjection of artificial chromosome constructs; immunofluorescence for CENP-A, KNL-2, and acetylation marks; epistasis analysis |
Nucleic acids research |
High |
33872374
|
| 2023 |
A hemizygous truncating mutation in RBBP7 (affecting the sixth WD40 domain) abrogates interaction with histone H4 and causes maturation arrest in spermatogenesis; Drosophila Caf1-55 (RBBP7 ortholog) knockdown in germ cells eliminates germ cells, while knockdown in cyst cells causes hyperproliferative testicular cells, and male infertility is rescued by wild-type human RBBP7 but not mutant variants. |
Human genetic variant identification; domain mapping by mutation analysis; Co-IP for histone H4 interaction; γH2AX and BRCA1 Western blot; Drosophila germline-specific and cyst cell-specific RNAi; rescue with wild-type vs. mutant human RBBP7 |
The Journal of clinical investigation |
High |
37843278
|
| 2024 |
SP1 transcription factor directly activates the RBBP7 promoter; RBBP7 in turn activates PI3K/AKT signaling to promote glycolysis (Warburg effect) and hepatocellular carcinoma cell proliferation. |
Dual-luciferase reporter assay for SP1-RBBP7 promoter; chromatin immunoprecipitation; Western blot for PI3K/AKT phosphorylation; CCK8 and colony formation; measurement of glycolytic enzymes and metabolites |
Journal of translational medicine |
Medium |
38368381
|
| 2025 |
RBBP7 functions as a novel E3 ubiquitin ligase via covalent engagement at Cys97; ynamide-containing small-molecule degraders covalently engage Cys97 of RBBP7 to recruit it as the E3 ligase responsible for targeted degradation of multiple proteins including CDK4, PDE5, PI3K, AKT, BRD4, and mutant EGFR. |
Chemical proteomics (activity-based protein profiling); proteome profiling after degrader treatment; covalent labeling with ynamide electrophile; functional validation of target degradation by Western blot; site-specific mutagenesis (Cys97) |
Angewandte Chemie (International ed. in English) |
Medium |
40600340
|
| 2025 |
RBBP7 directly deacetylates Acsl4 at lysine 401, reducing Acsl4 acetylation; deacetylation of Acsl4-K401 increases its enzyme activity by promoting ATP binding, thereby enhancing ferroptosis and promoting ovarian aging. |
Acetyl-proteomics; immunoprecipitation-mass spectrometry (IP-MS) identifying RBBP7 as direct Acsl4 deacetylation mediator; site-specific acetylation mutant analysis; Acsl4 enzyme activity assay; ferroptosis assays in vivo and in vitro |
International journal of biological macromolecules |
Medium |
41478474
|
| 2025 |
RBBP7 interacts with LSD1 and recruits it to promoters of stemness genes (SOX9, SOX2, OCT4, CCND1) to erase repressive H3K9me3 marks, transcriptionally upregulating stemness gene expression and promoting breast cancer stem-like properties and metastasis. |
Co-immunoprecipitation for RBBP7-LSD1 interaction; ChIP-qPCR for H3K9me3 and LSD1 at stemness gene promoters; CRISPR/Cas9 deletion of RBBP7 super-enhancer; tumor sphere formation; tail vein metastasis model; PDO and PDX models |
Journal of translational medicine |
Medium |
40038738
|